ArticleVaccines2025

Development of an Influenza/COVID-19 Combination mRNA Vaccine Containing a Novel Multivalent Antigen Design That Enhances Immunogenicity of Influenza Virus B Hemagglutinins.

Elena Thornhill-Wadolowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.